











































Join us for a compelling fireside chat with Bettina Hein, CEO of juli, and Michele Geller of Noven Pharmaceuticals, as they share behind-the-scenes insights from building a digital companion app for a transdermal ADHD medication.
The app required specialized functionality to support this unique mode of drug delivery. Launched in January, the app marks a groundbreaking step in digital health.
Bettina and Michele will discuss the complex journey of creating a white-label solution in pharma—navigating legal hurdles, coordinating large cross-functional teams, aligning with the drug lifecycle, and ultimately, setting a new standard in patient engagement